Breaks Categories: Stock Spotlights

WednesdayMar 01, 2017 12:49 pm

NetworkNewsBreaks – SRAX (NASDAQ: SRAX) Presenting at 29th Annual ROTH Conference; CEO, CFO to Host Investor Meetings

SRAX (NASDAQ: SRAX), an Internet advertising and platform technology company that provides tools to automate the digital advertising market, is set to present at the 29th Annual ROTH Conference. The company’s presentation will take place on Monday, March 13, 2017, at 5:30 p.m. PT in Dana Point, CA. Additionally, the company’s chief executive officer, Chris Miglino, and chief financial officer, J.P. Hannan, will be hosting one-on-one meetings with investors throughout the day. If you are interested in scheduling a one-on-one meeting, please contact your ROTH representative. To view the full press release, visit: http://nnw.fm/2L0nt About SRAX SRAX is an Internet…

Continue Reading

TuesdayFeb 28, 2017 12:22 pm

NetworkNewsBreaks – NF Energy Saving Corp. (NASDAQ: NFEC) Shares Tick Higher on New Sales Contract

NF Energy (NASDAQ: NFEC) shares are up more than 10% after the energy saving service solutions provider for China's power said it recently signed a $340,000 sales contract with Sinkiang Production and Construction Group to supply a project with butterfly valves. This is the first contract signed in 2017 based upon China's "one belt and one road" developmental strategy for the future. NF Energy intends to use this strategy to expand its market by growing is brand in its local region and nearby countries. Per the agreement, the company is expected to deliver this equipment in the third quarter of…

Continue Reading

TuesdayFeb 28, 2017 9:41 am

NetworkNewsBreaks – aTyr Pharma, Inc.’s (NASDAQ: LIFE) Resolaris™ Granted Orphan Drug Designation for the Treatment of Limb Girdle Muscular Dystrophy; Shares Higher

Shares of aTyr Pharma (NASDAQ: LIFE) are up more than 15% after the company said its lead product candidate, Resolaris™, received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for the treatment of limb girdle muscular dystrophy (LGMD) patients. Resolaris is derived from a naturally occurring protein released by human skeletal muscle cells and is being developed as an intravenous protein therapeutic for the treatment of rare myopathies with an immune component, such as LGMD. Being granted Orphan Drug Designation by the FDA will advance the development of Resolaris and create opportunity for incentives under the program.…

Continue Reading

MondayFeb 27, 2017 12:01 pm

NetworkNewsBreaks – OncoSec’s (NASDAQ: ONCS) ImmunoPulse® IL-12 Receives Fast Track Designation to Treat Metastatic Melanoma

OncoSec Medical (NASDAQ: ONCS) has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for its ImmunoPulse® IL-12, a potentially first-in-class, Intratumoral anti-cancer gene therapy that expresses interleukin-12 (IL-12) for the treatment of metastatic melanoma, following progression on pembrolizumab or nivolumab. The company this morning announced that this designation permits frequent communications and meetings with the FDA, providing opportunity for the upcoming phase 2b PISCES clinical trial of ImmunoPulse® IL-12 in combination with an intravenous anti-PD-1 antibody. The clinical trial is planned to initiate in the first half of 2017. "With the recent presentation of our interim…

Continue Reading

FridayFeb 24, 2017 11:10 am

NetworkNewsBreaks – Auris Medical’s (NASDAQ: EARS) AM-111 Receives FDA Fast Track Designation to Treat Acute Sensorineural Hearing Loss

Auris Medical (NASDAQ: EARS) shares rose 13% this morning on news of the reception of Fast Track designation for AM-111 in the treatment of acute sensorineural hearing loss (ASNHL) from the U.S. Food and Drug Administration (FDA). The company is currently evaluating AM-111 in two phase 3 clinical trials. The first is the HEALOS trial, which is being conducted in several European and Asian countries. Auris Medical expects to complete enrollment in the second quarter of 2017 and report top-line results from this trial in the third quarter of 2017. The second trial, ASSENT, is being conducted in the U.S.,…

Continue Reading

ThursdayFeb 23, 2017 11:26 am

NetworkNewsBreaks – eXp World Holdings, Inc. (EXPI) Adds Over 100 New Agents and Brokers in Tough Climate

While market reports show low inventory of houses on the market, eXp World Holdings doesn’t seem to be affected by the overall concern for real estate businesses in the United States. In fact, the company continues to grow. “Although the end of 2016 showed cause for concern for real estate businesses across the country, inventory for January moved at a 4% faster annual rate (http://nnw.fm/obP83). This stronger than usual off-season has left a low volume of available homes for sale with very high prices. But this dip in volume has not halted the rising interest in eXp World Holdings, Inc.…

Continue Reading

ThursdayFeb 23, 2017 11:21 am

NetworkNewsBreaks – Singlepoint, Inc. (SING) Forecasts Growth through Acquisitions, Joint Ventures in 2017

Singlepoint’s (OTC: SING) founder, president and CEO Greg Lambrecht recently gave an interview on Money TV with Donald Baillargeon, discussing the company’s acquisition strategy and recent stock performance. “The company’s massive success on the market in terms of stock price and volume has also drawn the interest of institutional investors. We’re getting a lot of attention from Wall Street and other that, even though we’re a Pink and right now we’re offering rule 144, that doesn’t seem to bother them. With our volume and stock price, we have a lot of interested parties that want to invest in Singlepoint and I…

Continue Reading

WednesdayFeb 22, 2017 10:44 am

NetworkNewsBreaks – Stealth Technologies, Inc. (STTH) Attends Leading Real Estate, Home Staging Conference as Part of Strategic Growth Initiative

Security and personal protection company Stealth Technologies, Inc. (OTCQB: STTH) this morning offered an update on its attendance at the International Association of Home Staging Professionals (IAHSP) and Real Estate Conference Expo in Fort Lauderdale, Florida. The company recently attended the conference as part of its ongoing efforts to expand its product footprint across various industries and distributors, providing an opportunity for Stealth Technologies to showcase its innovative products while networking with key industry professionals. “We believe the conference was a success as it introduced our innovative products to various potential distributors and formed strategic relationships with industry leaders,” Brian…

Continue Reading

TuesdayFeb 21, 2017 11:50 am

NetworkNewsBreaks – Rentech, Inc. (NASDAQ: RTK) Plummets 45% on Halted Production at Wawa Facility

Shares of Rentech (NASDAQ: RTK) are down 46% following the company’s announcement that its board has decided to idle the Wawa facility due to equipment and operational issues that would require additional unbudgeted capital investment, as well as continued uncertainty around profitability on pellets produced at the facility. The company said it expects to complete a safe and orderly idling of the facility in approximately two weeks. After the plant is idled, a small number of workers will maintain the plant so that it can resume operations with minimal resources if there is interest from a third party to invest…

Continue Reading

TuesdayFeb 21, 2017 11:48 am

NetworkNewsBreaks – Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) Initiates Collaborative Research Program with Viatar for Early Pancreatic Cancer Detection

Interpace Diagnostics (NASDAQ: IDXG) is trading higher on news of its collaborative research program with Viatar CTC Solutions Inc. The partnership will combine Viatar's circulating tumor cell collection technology with Interpace's commercialized PancraGEN™ assay used to help assess unknown pancreatic cancer biopsies in patients with pancreatic cysts. Studies are being designed to identify patients most likely to develop pancreatic cancer in the near future as well as to detect pancreatic cancer at its earliest stage of development. These studies may lead to the enactment of early diagnostic testing and assessment for patients with pancreatic diseases, as well as for those…

Continue Reading